AVR 0.43% $18.68 anteris technologies ltd

Ann: Regulatory approval to launch CardioCel in India, page-64

  1. 13,915 Posts.
    lightbulb Created with Sketch. 124
    Yup heart surgery is probably completely and utterly out of reach of the majority of the population. Market size? Maybe a rough guide would be to apply the incidence/prevalence of CHD in the population that has private health insurance (going by the above link, thats about 5% of the population or 66 million have private health insurance).

    Using the figures used by other posters:

    Number of private health insured = 66 million
    Population growth = 2% x 66 million = 1.3 million p.a.
    Incidence of CHD = 1% x 1.3 million = 13,200 p.a.
    Number of operations = 25% x 13,200 = 3,300 p.a.

    The country in itself wont be a company maker but its another market to add to the list and for sure over time a progressively larger segment of the population in India will join the ranks of those that can afford proper healthcare.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.68
Change
0.080(0.43%)
Mkt cap ! $357.9M
Open High Low Value Volume
$18.62 $18.68 $18.62 $53.20K 2.857K

Buyers (Bids)

No. Vol. Price($)
1 25 $18.42
 

Sellers (Offers)

Price($) Vol. No.
$18.62 124 2
View Market Depth
Last trade - 10.51am 24/06/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.